Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated wi...
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807
About this item
Full title
Author / Creator
Ura, Takashi , Hironaka, Shuichi , Tsubosa, Yasuhiro , Mizusawa, Junki , Kato, Ken , Tsushima, Takahiro , Fushiki, Kunihiro , Chin, Keisho , Tomori, Akihisa , Okuno, Tatsuya , Matsushita, Hisayuki , Kojima, Takashi , Doki, Yuichiro , Kusaba, Hitoshi , Fujitani, Kazumasa , Seki, Shiko and Kitagawa, Yuko
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Background
We herein investigated the association between early tumor shrinkage (ETS) and depth of response (DpR) and clinical outcomes in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil (bDCF) using data from the JCOG0807, a phase I/II trial of bDCF as first-line chemotherapy...
Alternative Titles
Full title
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2740509285
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2740509285
Other Identifiers
ISSN
1612-9059
E-ISSN
1612-9067
DOI
10.1007/s10388-022-00968-9
